Sort
85,873 grants matching “alzheimers”
The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease
$1,433,753Bruce A Wasserman · Johns Hopkins University · R01 · FY2016 · AG
Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU
$1,433,652Vladislav Bergo · Adeptrix Corporation · R44 · FY2023 · AG
PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment
$1,433,260Michela Gallagher · Johns Hopkins University · R01 · FY2019 · AG
Admin Core
$1,433,058Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2022 · AG
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia: Supplement; Framingham Heart Study Brain Aging Program (FHS-BAP)
$1,433,058Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2022 · AG
The Longitudinal Course O\F Imaging Biomarkers in People At RISK of AD
$1,432,880Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2018 · AG
Assessment of Candidate Loci in Neurological diseases
$1,432,795Andrew Singleton · National Institute On Aging · ZIA · FY2023 · AG
New Approaches to Dementia Heterogeneity
$1,431,876Bruce L Miller · University Of California, San Francisco · P50 · FY2008 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis
$1,431,396Dongming Cai · Icahn School Of Medicine At Mount Sinai · RF1 · FY2021 · AG
Hybrid efficacy-effectiveness trial to promote goals-of-care discussions for patients with Alzheimer's disease and related dementias and their family caregivers
$1,431,369Erin Kathryn Kross · University Of Washington · R01 · FY2024 · AG
Hybrid efficacy-effectiveness trial to promote goals-of-care discussions for patients with Alzheimer's disease and related dementias and their family caregivers
$1,431,369Erin Kathryn Kross · University Of Washington · R01 · FY2023 · AG
Hybrid efficacy-effectiveness trial to promote goals-of-care discussions for patients with Alzheimer's disease and related dementias and their family caregivers
$1,431,369Erin Kathryn Kross · University Of Washington · R01 · FY2022 · AG
Mayo Clinic Metabolomics Resource Core
$1,431,355K. Sreekumaran Nair · Mayo Clinic Rochester · U24 · FY2017 · DK
Genetic Epidemiology of Alzheimer's Disease in African Americans
$1,431,053Jennifer Jaie Manly · Columbia University Health Sciences · R01 · FY2009 · AG
Connectome 2.0: A BRAIN Technology Integration and Dissemination Resource for Ultra-High Gradient Magnetic Resonance Imaging of Human Brain Circuits Across Scales
$1,430,923Susie Yi Huang · Massachusetts General Hospital · U24 · FY2024 · NS
MITOCHONDRIAL DYSFUNCTION IN NEUROGEGENERATION OF AGING
$1,430,806Winifred Masterson Burke Med Res Inst · P01 · FY2005 · AG
Adult Changes in Thought (ACT) Research Program Core F: Data and Analysis Core
$1,430,697Rod Walker · Kaiser Foundation Research Institute · U19 · FY2024 · AG
Pre-Clinical Testing Core
$1,430,214Paul Richard Territo · Indiana University Indianapolis · U54 · FY2020 · AG
HABS-HD - Core G - Development Core
$1,429,938Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2023 · AG
Novel Mechanistic Targets of Steroid Hormones in the Brain
$1,429,132Meharvan Singh · University Of North Texas Hlth Sci Ctr · P01 · FY2010 · AG
Down Syndrome Connect Registry
$1,428,725Joaquin M. Espinosa · University Of Colorado Denver · OT2 · FY2024 · HD
EXTENDING INDEPENDENCE AND QUALITY OF LIFE FOR PEOPLE WITH ALZHEIMER'S DISEASE OR DEMENTIA THROUGH TELEHEALTH PROGRAM DELIVERY
$1,428,688Cynthia Louise Benjamin · Together Senior Health, Inc. · R44 · FY2020 · AG
NEUROBIOLOGY OF ALZHEIMER'S DISEASE AND AGING
$1,428,536University Of Texas Sw Med Ctr/Dallas · P30 · FY2002 · AG
Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome
$1,428,499Travis Dunckley · Iluminos Therapeutics, Llc · R44 · FY2025 · NS
Alzheimer's disease drug development
$1,428,086Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG